A mobile health application for controlling symptoms of chronic obstructive pulmonary disease: a randomised controlled trial

Abstract

Objectives: The effect of the mobile health application developed for controlling symptoms of patients with COPD on self-efficacy and chronic disease management was evaluated in the study. Methods: After the development of mCOPD (mKOAH in Turkish) the data of patients who met the inclusion criteria were collected face-to-face and the last test was collected with remote telehealth applications. In the collection of data; Patient Data Form, COPD Assessment Test (CAT), Modified Medical Research Council Dyspnea Scale (mMRC), COPD Self-Efficacy Scale (CSES), Patient Assessment of Chronic Illness Care (PACIC), Satisfaction Survey and mCOPD mobile application were used. Results: There was no significant difference between the pretest symptom values (mMRC, CAT), CSES and PACIC scores of the trial and control group patients (p > 0.05). mCOPD application 3 months after significant improvement was found in the symptoms, CSES, PACIC scores of the trial group patients compared to the control group patients (p < 0.05). The trial group had decreased health care usage compared to control group patients (p < 0.05). Conclusions: mCOPD (mKOAH in Turkish) improved the control of the symptoms, increased self-efficacy and chronic disease management in COPD patients and reduced health care use. (c) 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.